MAR 27·Stock TitanMed
Buda Juice (BUDA) 2025 report: profits, key customer risk and expansion
Buda Juice, Inc. (BUDA) has filed its 2025 annual report, revealing net profits of $3.53 million for 2025 and $3.57 million for 2024, despite a decrease in gross profit margin due to higher produce costs. The company, which specializes in UltraFresh™ cold-crafted citrus juices, highlights a significant customer concentration risk, with one customer accounting for 97% of its 2025 net sales. Buda Juice plans a strategic three-hub expansion into South Carolina and Arizona/Nevada to mitigate this risk and serve a broader U.S. consumer base.